Aquatic Capital Management LLC Has $376,000 Stock Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Aquatic Capital Management LLC cut its stake in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 49.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,165 shares of the company's stock after selling 4,035 shares during the quarter. Aquatic Capital Management LLC's holdings in iRhythm Technologies were worth $376,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Barclays PLC increased its holdings in iRhythm Technologies by 34.3% in the third quarter. Barclays PLC now owns 209,247 shares of the company's stock worth $15,534,000 after buying an additional 53,498 shares during the last quarter. Stephens Investment Management Group LLC increased its position in iRhythm Technologies by 25.6% during the fourth quarter. Stephens Investment Management Group LLC now owns 502,925 shares of the company's stock worth $45,349,000 after buying an additional 102,600 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in iRhythm Technologies by 9.6% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 570,048 shares of the company's stock worth $50,991,000 after buying an additional 50,075 shares during the last quarter. KBC Group NV raised its holdings in iRhythm Technologies by 45.1% during the fourth quarter. KBC Group NV now owns 1,319 shares of the company's stock valued at $119,000 after buying an additional 410 shares in the last quarter. Finally, Invesco Ltd. lifted its position in shares of iRhythm Technologies by 1.1% in the fourth quarter. Invesco Ltd. now owns 19,200 shares of the company's stock worth $1,731,000 after buying an additional 207 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on IRTC shares. Wells Fargo & Company raised shares of iRhythm Technologies from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $104.00 to $130.00 in a research report on Friday. The Goldman Sachs Group lifted their price target on iRhythm Technologies from $91.00 to $124.00 and gave the stock a "neutral" rating in a research report on Monday, February 24th. Needham & Company LLC raised their price objective on shares of iRhythm Technologies from $138.00 to $151.00 and gave the stock a "buy" rating in a research note on Friday. Canaccord Genuity Group cut their target price on shares of iRhythm Technologies from $152.00 to $139.00 and set a "buy" rating for the company in a research note on Friday. Finally, Oppenheimer upped their price objective on shares of iRhythm Technologies from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Wednesday, January 8th. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $128.55.

iRhythm Technologies Price Performance

IRTC stock traded up $4.64 during midday trading on Monday, reaching $135.76. 1,269,219 shares of the company's stock traded hands, compared to its average volume of 467,000. The company has a 50-day simple moving average of $104.12 and a two-hundred day simple moving average of $96.91. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00. iRhythm Technologies, Inc. has a 1-year low of $55.92 and a 1-year high of $138.42. The company has a market cap of $4.33 billion, a price-to-earnings ratio of -37.30 and a beta of 1.34.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported ($0.95) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.06). iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. The company had revenue of $158.68 million during the quarter, compared to analyst estimates of $153.39 million. During the same quarter in the previous year, the business posted ($1.23) EPS. The company's revenue was up 20.3% compared to the same quarter last year. On average, analysts anticipate that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current year.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.